You are here: Industry Insights > CAGR

News List

Rapid microbiology testing market set to be worth over $6 billion in 2026 europeanpharmaceuticalreview
January 11, 2021
Rising at a CAGR of 8.2 percent, the rapid microbiology testing market is predicted to grow over the next five years.
Protein crystallisation and crystallography market to reach almost $2 billion europeanpharmaceuticalreview
January 07, 2021
Growth of the global protein crystallisation and crystallography market is attributed to increasing interest in biologics, more investment and advancing technologies.
Global Biosimilars Market Poised to Grow at Chart-topping Levels with a CAGR of 17.3%, Reaching $79.2 Billion by 2026 prnasia
December 11, 2020
Frost & Sullivan's recent analysis, Access to New Therapy Areas to Drive Major Growth in the Global Biosimilars Market, 2020–2026, finds that the cost-benefit for end-users (patients) and ease of partnering with specialty contract development and ...
Lateral flow assay market set to be worth $10.2 billion in 2025 europeanpharmaceuticalreview
November 19, 2020
Rising at a CAGR of 4.5 percent, the lateral flow assays market is projected increase due to the high prevalence of infectious diseases worldwide.
T2D market will grow from a total of $48.1bn sales in 2019 to $91.9 bn in 2029 expresspharma
November 18, 2020
T2D market growth factors are increasing diagnosed prevalence of disease and emergence of novel pipeline agents.
Nasal drug delivery technology market to grow at CAGR of 5.1 percent europeanpharmaceuticalreview
October 23, 2020
A new report has shown that through the COVID-19 pandemic, the global nasal drug delivery technology market is predicted to increase.
Global ALS market may grow to $1.04 bn in 2029 driven by anticipated drug launches expresspharma
October 09, 2020
A GlobalData report also informs that there are major unmet needs in the ALS market, such as finding curative drugs, receiving earlier diagnosis, identifying reliable biomarkers and extending patient survival.
Global HPAPI market to grow at CAGR of 8.7 percent by 2026 europeanpharmaceuticalreview
September 30, 2020
A report has said that the highly potent compound market will grow to be worth $32,200 million by the end of 2026.
$392.4 Million Worldwide Adult Hemoglobinopathy Testing Industry to 2027 - Impact of COVID-19 prnewswire
September 24, 2020
Amid the COVID-19 crisis, the global market for Adult Hemoglobinopathy Testing estimated at US$330.3 Million in the year 2020, is projected to reach a revised size of US$392.4 Million by 2027, growing at a CAGR of 2.5% over the analysis period 2020-2027.
$3.7 Billion Worldwide Hemostasis Diagnostics Industry to 2027 - Impact of COVID-19 on the Market prnewswire
September 08, 2020
Amid the COVID-19 crisis, the global market for Hemostasis Diagnostics estimated at US$2.3 Billion in the year 2020, is projected to reach a revised size of US$3.7 Billion by 2027, growing at a CAGR of 7% over the analysis period 2020-2027.

Previous page 1 2 3 4 5 6 7 8 Next page